Evaluation of a novel precision template-guided biopsy system for detecting prostate cancer

BJU International

Volumn 102, Issue 5, 2008, Pages 546-550

  Megwalu, Ifeanyichukwu I ^a   Ferguson, Genoa G ^a   Wei, John T ^c   Mouraviev, Vladimir ^d   Polascik, Thomas J ^d   Taneja, Samir ^e   Black, Linda ^a   Andriole, Gerald L ^a,b   Kibel, Adam S ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biopsy; Diagnosis; Prostatic neoplasms; Sampling

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIGITAL RECTAL EXAMINATION; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE DISEASE; PROSTATECTOMY; RETROSPECTIVE STUDY; TRANSRECTAL ULTRASONOGRAPHY; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; BIOPSY; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECTUM; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 48749128493     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07832.x     Document Type: Article

References (20)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2007. CA Cancer J Clin 2007 57 : 43 66
2. Tarone RE, Chu KC, Brawley OW. Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates. Epidemiology 2000 11 : 167 70
3. Andriole GL, Bullock TL, Belani JS et al. Is there a better way to biopsy the prostate? Prospects for a novel transrectal systematic biopsy approach. Urology 2007 70 : 22 6
4. Loch T. Urologic imaging for localized prostate cancer in 2007. World J Urol 2007 25 : 121 9
5. Freedland SJ, Aronson WJ, Csathy GS et al. Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database. Urology 2003 61 : 742 7
6. Presti JC Jr. Prostate biopsy: how many cores are enough? Urol Oncol 2003 21 : 135 40
7. Presti JC Jr, Chang JJ, Bhargava V, Shinohara K. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol 2000 163 : 163 6
8. Presti JC Jr, O'Dowd GJ, Miller MC, Mattu R, Veltri RW. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol 2003 169 : 125 9
9. Raaijmakers R, Kirkels WJ, Roobol MJ, Wildhagen MF, Schroder FH. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 2002 60 : 826 30
10. Siddiqui EJ, Ali S, Koneru S. The rectal administration of lignocaine gel and periprostatic lignocaine infiltration during transrectal ultrasound-guided prostate biopsy provides effective analgesia. Ann R Coll Surg Engl 2006 88 : 218 21
11. de Jesus CM, Correa LA, Padovani CR. Complications and risk factors in transrectal ultrasound-guided prostate biopsies. Sao Paulo Med J 2006 124 : 198 202
12. Etzioni R, Penson DF, Legler JM et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 2002 94 : 981 90
13. Kozlowski P, Chang SD, Jones EC, Berean KW, Chen H, Goldenberg SL. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis - correlation with biopsy and histopathology. J Magn Reson Imaging 2006 24 : 108 13
14. Kumar V, Jagannathan NR, Kumar R et al. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/mL. N MR Biomed 2007 20 : 11 20
15. Gore JL, Shariat SF, Miles BJ et al. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol 2001 165 : 1554 9
16. Guichard G, Larre S, Gallina A et al. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients. Eur Urol 2007 52 : 430 5
17. Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol 2000 164 : 388 92
18. Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994 271 : 368 74
19. Mian BM, Lehr DJ, Moore CK et al. Role of prostate biopsy schemes in accurate prediction of Gleason scores. Urology 2006 67 : 379 83
20. Remzi M, Fong YK, Dobrovits M et al. The Vienna Nomogram. Validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. J Urol 2005 174 : 1256 60